Cargando…

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database

Background: Progressive supranuclear palsy is a rare neurodegenerative movement disorder and little is known about its epidemiology. Objective: Estimate age-adjusted prevalence of progressive supranuclear palsy and describe antecedent diagnoses and progressive supranuclear palsy patient features in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viscidi, Emma, Litvan, Irene, Dam, Tien, Juneja, Maneesh, Li, Li, Krzywy, Henry, Eaton, Susan, Hall, Susan, Kupferman, Joseph, Höglinger, Günter U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245849/ https://www.ncbi.nlm.nih.gov/pubmed/34220661 http://dx.doi.org/10.3389/fneur.2021.571800

Ejemplares similares

Increased Risk of Venous Thromboembolism in Patients With Amyotrophic Lateral Sclerosis: Results From a US Insurance Claims Database Study
por: Kupelian, Varant, et al.
Publicado: (2023)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019)

Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Environmental Risk Factors for Progressive Supranuclear Palsy
por: Park, Hee Kyung, et al.
Publicado: (2021)

An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
por: Kurz, Carolin, et al.
Publicado: (2016)

Gene-Environment Interactions in Progressive Supranuclear Palsy
por: Litvan, Irene, et al.
Publicado: (2021)

Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
por: Kwasny, Mary J., et al.
Publicado: (2021)

Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
por: Klietz, Martin, et al.
Publicado: (2021)

Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans
por: Kelley, Kristen D., et al.
Publicado: (2018)

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study
por: Viscidi, Emma, et al.
Publicado: (2021)

Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020)

Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
por: Grimm, Max-Joseph, et al.
Publicado: (2020)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
por: Pereira, Marta F, et al.
Publicado: (2022)

Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
por: Simoes, Fabio A., et al.
Publicado: (2022)

Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy
por: Höglinger, Günter U., et al.
Publicado: (2011)

Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
por: Rogozinski, Sophia, et al.
Publicado: (2022)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
por: Marx, Svenja, et al.
Publicado: (2012)

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype
por: Jabbari, Edwin, et al.
Publicado: (2018)

Exercise and Progressive Supranuclear Palsy: the need for explicit exercise reporting
por: Slade, Susan C., et al.
Publicado: (2019)

Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls
por: Viscidi, Emma, et al.
Publicado: (2021)

Correction to: Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls
por: Viscidi, Emma, et al.
Publicado: (2022)

The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis
por: Chen, Athena L., et al.
Publicado: (2010)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Clinical Approach to Progressive Supranuclear Palsy
por: Ling, Helen
Publicado: (2016)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Hummingbird sign in progressive supranuclear palsy
por: Verma, Rajesh, et al.
Publicado: (2012)

Imaging in the diagnosis of progressive supranuclear palsy
por: Smith, Matthew D., et al.
Publicado: (2018)

Multireceptor fingerprints in progressive supranuclear palsy
por: Chiu, Wang Zheng, et al.
Publicado: (2017)

Progressive supranuclear palsy: diagnosis and management
por: Rowe, James B, et al.
Publicado: (2021)

Understanding fatigue in progressive supranuclear palsy
por: Ahn, Jong Hyeon, et al.
Publicado: (2021)

Autonomic dysfunction in progressive supranuclear palsy
por: Baschieri, Francesca, et al.
Publicado: (2022)

Clinical features of progressive supranuclear palsy
por: Wen, Yafei, et al.
Publicado: (2023)

[(18)F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6hq3jfdk6uu9nqcplqa6fhutbt